About GMPPro
GMPPro is a company based in Hyderabad (India). It operates as a B2B. The company has 34 employees. GMPPro operates in a competitive market with competitors including Indegene, Zuellig Pharma, IntegriChain, Clinigen and Science Group, among others.
- Headquarter Hyderabad, India
- Employees 34
- SectorsHealthcare
- Website quickgmp.com
- Legal Name Motto Systems Pvt. Ltd.
- Date of Incorporation 03 Apr, 2013
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹4.12 Cr
FY 2025 · +18% YoY
- Net Profit₹21.1 Lakh
FY 2025 · 5% margin
- EBITDA₹52.7 Lakh
FY 2025 · 13% margin
- Employee Count34
Associated legal entities of GMPPro
GMPPro operates through Motto Systems Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Motto Systems Private Limited CIN U72900TG2013PTC086770 | Active | 03 Apr 2013 | Hyderabad, Telangana | ₹4.1 Cr | 34 | 3 | View details |
Board of directors of Motto Systems Private Limited (GMPPro)
Motto Systems Private Limited is the primary company behind GMPPro. The board of Motto Systems Private Limited currently have 3 directors; the longest-serving is Nagadhar Ravi Chandra Penmetsa, appointed in 2017. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nagadhar Ravi Chandra Penmetsa DIN 00034802 | Whole-time director | 30 Oct 2017 | 8 yrs 11 mo | Motto Systems Private Limited |
| Venkata Jagan Mohan Burla DIN 03492665 | Director | 14 Feb 2022 | 4 yrs 7 mo | Motto Systems Private Limited |
| Penmetsa Mani Prakash Varma DIN 11430422 | Additional Director | 17 Dec 2025 | 9 mo | Motto Systems Private Limited |
Financials of GMPPro
Figures of Motto Systems Private Limited, the primary company behind GMPPro, for FY 2025. Revenue was ₹4.12 Cr (+18% year on year). Net profit was ₹21.1 Lakh (5% margin). EBITDA was ₹52.7 Lakh (13% margin). Revenue has grown at a compounded annual rate of +18% over three years and +7% over five years.
- ₹4.12 CrRevenue · FY 2025 · +18% YoY
- ₹21.1 LakhNet profit · 5% margin
- ₹52.7 LakhEBITDA · 13% margin
- ₹40.9 LakhPaid-up capital
- 34Employees (provident fund records)
- +18%Revenue CAGR, 3 years
- +7%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Motto Systems Private Limited are on its company page.
Detailed financial statements for GMPPro
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of GMPPro
GMPPro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, Zuellig Pharma, IntegriChain, Clinigen and Science Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indegene.com | 1998 | Princeton, United States | $255.15M | 350 | Suite solutions are provided for payers and healthcare providers. | |
| zuelligpharma.com | 1992 | Singapore | – | – | Healthcare access in Asia is enhanced by Zuellig Pharma. | |
| integrichain.com | 2005 | Philadelphia, United States | $2M | 320 | Inventory, order and customer relationship management solution for life science suppliers. | |
| clinigengroup.com | 2010 | Burton-on-trent, United Kingdom | – | – | Specialty medicines are supplied via clinical trials and access programs. | |
| sciencegroup.com | 1995 | Cambridge, United Kingdom | – | 431 | Technology-based consultancy and product development services are provided. | |
| clearviewhcp.com | 2008 | Newton, United States | – | 381 | Strategic consulting services are provided to life sciences companies. | |
| fabtechnologies.com | 2002 | Mumbai, India | $175,048 | 279 | Instruments for biotech, pharmaceutical, and biomedical sectors are manufactured. |
Detailed competitors of GMPPro
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of GMPPro
The website of GMPPro (quickgmp.com) receives about 1.2K visits a month.
- Monthly visits1.2K
Similar companies to GMPPro
10 companies that operate in the same segment as GMPPro (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GMPPro
GMPPro is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
GMPPro has 34 employees.
The primary company behind GMPPro, Motto Systems Private Limited, reported revenue of ₹4.12 Cr for FY 2025, up 18% year on year.
GMPPro operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, drug development, and quality compliance. Provides auditing, quality compliance, and related services for drug development companies. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
GMPPro's top competitors include Indegene, Zuellig Pharma and IntegriChain.
GMPPro operates through Motto Systems Private Limited.
The legal entities of GMPPro currently have 3 directors, including Venkata Jagan Mohan Burla, Nagadhar Ravi Chandra Penmetsa, Penmetsa Mani Prakash Varma.